BioXcel Therapeutics Shares Up on Promising Study Results

BioXcel Therapeutics shares are trading higher after the company announced promising results from a study published in the journal Frontiers in Pharmacology, highlighting the potential of dexmedetomidine, the active ingredient in BXCL-501, for treating stress-mediated behaviors.